Evidence map›Paper›PMID 42807251›Full record

ReviewFrontiers in immunology2026

The role of macrophages in cardiac diseases: a review of the origins, functional diversity, and therapeutic potential.

Li Che, Zilong Wang

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Li CheDepartment of Cardiology, Central Hospital of Dalian University of Technology, Dalian, China.
Zilong WangDepartment of Neurosurgery, The First People's Hospital of JinZhou District, Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages are important immune cells for cardiac development, homeostasis, and the response to pathological injury and inflammation. Single-cell sequencing and fate-mapping technologies have revealed the heterogeneity and development of cardiac macrophages. They are classed into two main groups: embryonic tissue-resident and bone marrow-derived macrophages. These different macrophage subsets show complex functions in cardiac diseases such as inflammation regulation, tissue repair, metabolic reprogramming and intercellular communication within the cardiac microenvironment. This review discusses the developmental sources, phenotypic diversity, metabolic features and mechanistic functions of cardiac macrophages in different cardiac disorders. We focus on macrophage polarization, metabolic regulation during disease progression and targeted strategies and future research directions.

Indexed as

Heart DiseasesMacrophagesAnimalsHumansMacrophage ActivationMetabolic Reprogrammingcardiac diseasesimmune regulationmacrophagesmetabolic reprogrammingtherapeutic strategies

Identifiers

PMID42807251
PMCPMC13617374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.